Monday, September 24:
- No IPOs expected.
Tuesday, September 25:
- Viomi Technology (VIOT): The China-based developer of an IoT home platform connecting a suite of complementary consumable products is expected to price its 11.4 mln ADS IPO within a range of $9-$11.
Wednesday, September 26:
- Arco Platform (ARCE): The Brazil-based provider of educational content through printed and digital formats is expected to price its 11.1 mln ADS IPO within a range of $15.50-$17.50.
- Capital Bancorp (CBNK): The bank holding company based in the Washington D.C. and Baltimore areas is expected to price its 2.2 mln share IPO within a range of $12.50-$14.50.
- SurveyMonkey (SVMK): The provider of survey software products is expected to price its 13.5 mln share IPO within a range of $9-$11.
- Entasis Therapeutics (ETTX): The clinical-stage biopharmaceutical company developing antibacterial products to treat serious infections is expected to price its 4.4 mln share IPO within a range of $16-$18.
Thursday, September 27:
- Arvinas (ARVN): The biopharmaceutical company developing therapies to degrade disease-causing proteins is expected to price its 6.7 mln share IPO within a range of $14-$16.
- LAIX, Inc. (LAIX): The China-based AI company creating products to popularize English learning is expected to price its 5.8 mln share IPO within a range of $11.50-$13.50.
- Ra Medical Systems (RMED): The commercial-stage medical device company focused on treatment of vascular and dermatological diseases is expected to price its 3.3 mln share IPO within a range of $14-$16.
- Sutro Biopharma (STRO): The clinical stage biopharma developing a variety of protein therapeutics for cancer and autoimmune disorders is expected to price its 5.0 mln share IPO within a range of $14-$16.
- Urovant Sciences (UROV): The clinical-stage biopharmaceutical company developing therapies for urologic disorders is expected to price its 10.0 mln share IPO within a range of $14-$16.
Friday, September 28:
- CooTek (CTK): The China-based mobile internet company developing a portfolio of applications is expected to price its 4.4 mln share IPO within a range of $12-$14.
- Gritstone Oncology (GRTS): The immuno-oncology company developing tumor-specific cancer immunotherapies to fight multiple cancer types is expected to price its 6.1 mln share IPO within a range of $13-$15.